Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study
Sebastian Unizony, Mark Matza, A. Jarvie, David O’Dea, Ana D. Fernandes, John H. Stone
Topics & Concepts
Giant cell arteritisMedicinePrednisoneTocilizumabClinical endpointInternal medicineAdverse effectSurgeryGastroenterologyArteritisVasculitisRandomized controlled trialDiseaseVasculitis and related conditionsOtitis Media and Relapsing PolychondritisIgG4-Related and Inflammatory Diseases